You took antibiotics, gained weight, and can't lose it. Your genes may explain why.

FUT2 encodes a fucosyltransferase enzyme that decorates cells lining your gut with specific carbohydrate structures called ABO antigens. These structures are like a genetic nametag that tells bacteria which species are welcome to colonize your gut and which are not. Your FUT2 status essentially determines the primary composition of your gut microbiome.

If you’re a non-secretor (roughly 20% of people), your gut environment favors a very specific set of bacterial species. When antibiotics wipe out your microbiome, you need those exact species to come back, in the exact same ratios, to restore normal metabolism. Non-secretors experience much slower microbiome recovery after antibiotics, and often get stuck with a permanently altered bacterial composition. Their gut is fertile ground for pathogenic bacteria to take over, and the metabolic consequences can last months or years.

This means if you’re a non-secretor, generic probiotics won’t help. You need specific probiotic strains that are actually compatible with your FUT2 type. Standard post-antibiotic probiotics are designed for secretors and may not establish in your gut at all.

VDR, the vitamin D receptor, is a master regulator of intestinal barrier integrity. When vitamin D binds to VDR, it tells your intestinal cells to produce tight junction proteins that keep harmful bacteria and undigested food out of your bloodstream. VDR also regulates immune tolerance in your gut, telling your immune system to distinguish between commensal bacteria (the good ones you need) and pathogens.

Certain VDR variants, particularly the ff genotype (roughly 30% of people), impair this signaling. When your microbiome is disrupted by antibiotics, these VDR variants leave your intestinal barrier more vulnerable to permeability and your immune system more likely to attack the bacteria that are trying to recolonize. This means your gut becomes inflamed, your barrier gets leaky, and even beneficial bacteria get attacked instead of welcomed back.

If you have a VDR variant, a standard course of antibiotics doesn’t just clear the infection. It triggers a cascade of intestinal inflammation that can persist long after the infection is gone. Your immune system essentially stays in attack mode against your own beneficial bacteria.

MTHFR encodes methylenetetrahydrofolate reductase, the enzyme that converts dietary folate into the active form your cells use to methylate DNA, regulate gene expression, and produce energy. Methylation is happening in every cell in your body, constantly, and it’s especially critical in the intestinal lining and in the cells that regulate appetite and fat storage.

The MTHFR C677T variant, present in roughly 40% of the population, reduces this enzyme’s efficiency by 40 to 70%. When your microbiome is disrupted by antibiotics, your cells need to rapidly upregulate methylation to repair intestinal damage and reprogram appetite-control genes. If you have an MTHFR variant, you can’t methylate fast enough, so the repair process gets stuck. Your intestinal barrier stays inflamed, your appetite hormones stay dysregulated, and your metabolism never fully recovers.

This is why some people take antibiotics, lose their microbiome, and gain weight that doesn’t budge for years. Their MTHFR variant means they can’t initiate the genetic reset their metabolism needs to move on from the disruption.

FTO is the fat mass and obesity gene. It doesn’t make you fat directly. Instead, it controls appetite signaling in your hypothalamus, the part of your brain that decides when you’re full and should stop eating. FTO regulates how your brain interprets signals from your gut bacteria about nutrient availability and energy status.

If you carry the FTO A allele, present in roughly 45% of people of European ancestry, your appetite signaling is already less sensitive to satiety cues. When antibiotics destroy your microbiome, the bacteria that normally produce short-chain fatty acids (which signal fullness to your brain) disappear. With an FTO A allele variant, your brain gets no backup signal, so you never feel satisfied. You can eat a full meal and feel like you need more. This isn’t weakness. It’s a broken feedback loop.

The weight gain after antibiotics in FTO-variant carriers often comes from not overeating per se, but from never reaching satiety on normal portions. You eat what used to be enough, feel unsatisfied, and keep looking for more. Your brain is genuinely not receiving the fullness signal it needs to function normally.

PPARG encodes peroxisome proliferator-activated receptor gamma, a master regulator of fat cell development and function. PPARG tells your fat cells whether to store incoming calories as triglycerides or to remain metabolically active and responsive to fat-burning signals. PPARG also regulates insulin sensitivity. When PPARG signaling is strong, your fat cells are relatively insulin-sensitive and metabolically flexible. When it’s weak, your fat cells lock calories in and resist burning them.

The PPARG Pro12 allele, carried by roughly 25% of people, promotes efficient fat storage and reduces metabolic flexibility. When antibiotics disrupt your microbiome, the shift in bacterial composition changes which metabolites your gut produces, which alters insulin signaling in your fat cells. With a PPARG Pro12 variant, your fat cells respond to this change by entering storage mode and staying there. You’re not eating more. Your fat cells just become more efficient at holding onto calories and resisting mobilization.

This is particularly frustrating because exercise and calorie restriction don’t help much. Your fat cells are locked in storage mode at the genetic level. The problem isn’t effort. It’s your PPARG variant’s response to the altered microbiome.

TCF7L2 encodes a transcription factor that regulates insulin secretion from your pancreas in response to glucose. It’s the strongest known genetic risk factor for type 2 diabetes. TCF7L2 controls how well your pancreas responds to rising blood sugar by releasing enough insulin to bring it back down. It also regulates GLP-1 signaling, the pathway that tells your gut and brain about nutrient absorption and satiety.

The TCF7L2 T allele, present in roughly 30% of people, impairs incretin-stimulated insulin secretion. Incretins are hormones released by your gut in response to nutrients. When antibiotics wipe out your microbiome, the bacteria that help regulate incretin-producing cells disappear. With a TCF7L2 T allele, your pancreas is already less responsive to incretin signals, so the loss of microbial support causes blood sugar to rise and insulin to surge in an attempt to compensate. High insulin drives fat storage and suppresses fat burning. You’re essentially locked in metabolic storage mode.

Many people with TCF7L2 variants don’t realize they’ve developed insulin resistance after antibiotics because their fasting blood sugar still looks normal. But their insulin levels are silently climbing, driving weight gain and making fat loss nearly impossible despite normal diet and exercise.